These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28300430)

  • 1. Calculated Daily Insulin Dosages Overestimate Prescribed Insulin Doses in Type 2 Diabetes: A Primary Care Database Study.
    Kostev K; Rathmann W
    J Diabetes Sci Technol; 2017 May; 11(3):597-601. PubMed ID: 28300430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newer long-acting insulin prescriptions for patients with type 2 diabetes: prevalence and practice variation in a retrospective cohort study.
    Dankers M; Hek K; Nelissen-Vrancken M; Houweling ST; Mantel-Teeuwisse A; van Dijk L
    Br J Gen Pract; 2022 Jun; 72(719):e430-e436. PubMed ID: 35606162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial.
    Miser WF; Arakaki R; Jiang H; Scism-Bacon J; Anderson PW; Fahrbach JL
    Clin Ther; 2010 May; 32(5):896-908. PubMed ID: 20685497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effectiveness of biphasic insulin aspart 30:70 versus biphasic human insulin 30 in UK general clinical practice: a retrospective database study.
    Morgan CL; Evans M; Toft AD; Jenkins-Jones S; Poole CD; Currie CJ
    Clin Ther; 2011 Jan; 33(1):27-35. PubMed ID: 21397771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary-care-based analysis.
    Sharplin P; Gordon J; Peters JR; Tetlow AP; Longman AJ; McEwan P
    Cardiovasc Diabetol; 2009 Feb; 8():9. PubMed ID: 19220880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes treatment in people with type 2 diabetes and schizophrenia: Retrospective primary care database analyses.
    Rathmann W; Pscherer S; Konrad M; Kostev K
    Prim Care Diabetes; 2016 Feb; 10(1):36-40. PubMed ID: 25937183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early discontinuation and related treatment costs after initiation of Basal insulin in type 2 diabetes patients: a German primary care database analysis.
    Anderten H; Dippel FW; Kostev K
    J Diabetes Sci Technol; 2015 May; 9(3):644-50. PubMed ID: 25573957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Post-hoc analyses of type 2 diabetes patients switch from premixed insulin regimen to basal insulin plus oral hypoglycemic agents regimen].
    Bu S; Guo XH; Yang WY; Lu GZ; Yang ZJ; Ren TT; Gao Y
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3115-8. PubMed ID: 18269868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes.
    Vilsbøll T; Rosenstock J; Yki-Järvinen H; Cefalu WT; Chen Y; Luo E; Musser B; Andryuk PJ; Ling Y; Kaufman KD; Amatruda JM; Engel SS; Katz L
    Diabetes Obes Metab; 2010 Feb; 12(2):167-77. PubMed ID: 20092585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of basal insulin adherence using 2 methodologies among Texas Medicaid enrollees with type 2 diabetes.
    Zhang H; Barner JC; Moczygemba LR; Rascati KL
    J Manag Care Spec Pharm; 2020 Nov; 26(11):1434-1444. PubMed ID: 33119450
    [No Abstract]   [Full Text] [Related]  

  • 11. [Costs of diabetes care and treatment satisfaction in type 2 diabetes patients treated with a basal-bolus (ICT) insulin regimen in outpatient care: results of the LIVE-COM study].
    Bierwirth RA; Kohlmann T; Moock J; Holle R; Landgraf W
    Med Klin (Munich); 2010 Nov; 105(11):792-801. PubMed ID: 21136237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic control with insulin glargine plus insulin glulisine versus premixed insulin analogues in real-world practices: a cost-effectiveness study with a randomized pragmatic trial design.
    Levin PA; Zhang Q; Mersey JH; Lee FY; Bromberger LA; Bhushan M; Bhushan R
    Clin Ther; 2011 Jul; 33(7):841-50. PubMed ID: 21719107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycaemic control in patients with type 2 diabetes switching from premixed insulin to long-acting basal insulin analogue plus oral antidiabetic drugs: an observational study.
    Gómez-Peralta F; Carramiñana-Barrera F; Félix-Redondo FJ; Fraile-Gómez J;
    Int J Clin Pract; 2012 Oct; 66(10):959-68. PubMed ID: 22994330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of premixed insulin among the elderly. Reduction of errors in patient preparation of mixtures.
    Coscelli C; Calabrese G; Fedele D; Pisu E; Calderini C; Bistoni S; Lapolla A; Mauri MG; Rossi A; Zappella A
    Diabetes Care; 1992 Nov; 15(11):1628-30. PubMed ID: 1468295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study.
    Gordon J; Pockett RD; Tetlow AP; McEwan P; Home PD
    Int J Clin Pract; 2010 Nov; 64(12):1609-18. PubMed ID: 20946269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of insulin dosage with mortality or major adverse cardiovascular events: a retrospective cohort study.
    Gamble JM; Chibrikov E; Twells LK; Midodzi WK; Young SW; MacDonald D; Majumdar SR
    Lancet Diabetes Endocrinol; 2017 Jan; 5(1):43-52. PubMed ID: 27865756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, longitudinal, multicenter, observational study to assess insulin treatment patterns in diabetic patients in Thailand: results from the TITAN Study.
    Rawdaree P; Sarinnapakorn V; Pattanaungkul S; Khovidhunkit W; Tannirandorn P; Peerapatdit T
    J Med Assoc Thai; 2014 Nov; 97(11):1140-50. PubMed ID: 25675678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal change in HbA1c after insulin initiation in primary care patients with type 2 diabetes: a database analysis in UK and Germany.
    Rathmann W; Strassburger K; Tamayo T; Kostev K
    Prim Care Diabetes; 2012 Apr; 6(1):47-52. PubMed ID: 22099215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.